\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\uff08Human Research Ethics Committee; HREC\uff09\u7684\u6279\u51c6\u548c\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u7528\u54c1\u7ba1\u7406\u5c40\uff08Therapeutics Goods Administration; TGA\uff09<\/a>\u7684\u4e34\u5e8a\u8bd5\u9a8c\u901a\u77e5\u8ba1\u5212\u6279\u51c6\u3002<\/p>\n\u6b64\u5916\uff0cPeptron \u6839\u636e\u5408\u4f5c\u548c\u5236\u9020\u534f\u8bae\u751f\u4ea7\u7684 Presendin \u548c\u5b89\u6170\u5242\u836f\u7269\u4ea7\u54c1\u7684\u4e34\u5e8a\u4f9b\u5e94\u76ee\u524d\u6b63\u5728\u7b49\u5f85\u5728\u7f8e\u56fd\u8fdb\u884c\u6807\u7b7e\u6e05\u5173\uff0c\u7136\u540e\u518d\u53d1\u9001\u5230\u521d\u59cb\u4e34\u5e8a\u7ad9\u70b9\u3002<\/p>\n
\u65b0\u4efb\u9996\u5e2d\u8fd0\u8425\u5b98<\/h2>\n
\u4ece 7 \u6708\u521d\u5f00\u59cb\uff0cInvex \u8fd0\u8425\u4e3b\u7ba1 Carol Parish \u62c5\u4efb\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98\u7684\u5173\u952e\u6267\u884c\u804c\u52a1\u3002<\/p>\n
Parish \u5973\u58eb\u5728\u5236\u836f\/\u751f\u7269\u6280\u672f\u884c\u4e1a\u62e5\u6709\u8d85\u8fc7 33 \u5e74\u7684\u7ecf\u9a8c\uff0c\u5e76\u8d1f\u8d23\u591a\u4e2a\u6cbb\u7597\u9886\u57df\u7684\u836f\u7269\u5f00\u53d1\u7684\u6240\u6709\u9636\u6bb5\u3002<\/p>\n
\u5728\u52a0\u5165 Invex \u4e4b\u524d\uff0c\u5979\u662f Intercept Pharmaceuticals\uff08NASDAQ: ICPT\uff09\u7684\u5168\u7403\u4e34\u5e8a\u8fd0\u8425\u4e3b\u7ba1\uff0c\u5e76\u5728GlaxoSmithKline\u65d7\u4e0b\u7684 Stiefel Laboratories\u3001Merck & Co \uff08NYSE: MRK\uff09\u548cJohnson & Johnson\uff08NYSE: JNJ\uff09\u62c5\u4efb\u591a\u4e2a\u9ad8\u7ea7\u4e34\u5e8a\u804c\u4f4d.<\/p>\n
\u79d1\u5b66\u4f1a\u8bae\u6f14\u8bb2\u5f15\u8d77\u4e86\u4eba\u4eec\u5bf9 EVOLVE \u8bd5\u9a8c\u7684\u5174\u8da3<\/h2>\n
\u5728\u672c\u5b63\u5ea6\uff0cInvex \u5728\u4e13\u4e1a\u533b\u5b66\u4f1a\u8bae\u4e0a\u4e3b\u6301\u4e86\u8bb8\u591a\u4e0e IIH \u7b2c\u4e8c\u9636\u6bb5 PRESSURE \u8bd5\u9a8c\u7684\u4e3b\u8981\u53d1\u73b0\u6709\u5173\u7684\u6f14\u8bb2\u3002<\/p>\n
\u636e\u8be5\u516c\u53f8\u79f0\uff0c\u8be5\u8bd5\u9a8c\u7684\u540c\u884c\u8bc4\u5ba1\u8fc7\u7a0b\u901a\u8fc7\u4f17\u591a\u6f14\u793a\u6587\u7a3f\u5bfc\u81f4\u4e86\u5bf9 IIH EVOLVE \u7b2c\u4e09\u9636\u6bb5\u8bd5\u9a8c\u7684\u201c\u5f3a\u70c8\u7684\u79d1\u5b66\u548c\u533b\u5b66\u5174\u8da3\u201d\uff0c\u5e76\u201c\u6781\u5927\u5730\u4fc3\u8fdb\u4e86\u201d\u6709\u5173\u53c2\u4e0e\u7684\u8ba8\u8bba\u5ba1\u5224\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
Invex Therapeutics (ASX: IXC) \u5df2\u786e\u8ba4\u5176\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\uff0c\u56e0\u4e3a\u5b83\u5c06\u5f00\u59cb\u62db\u52df\u65b0\u8bca\u65ad\u7684\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269 Presendin \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u5728\u4eca\u5929\u53d1\u5e03\u7684 6 \u6708\u5b63\u5ea6\u62a5\u544a\u4e2d\uff0c\u8fd9\u5bb6\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\u5ba3\u5e03\uff0c\u5b83\u5df2\u4ece\u76ee\u524d\u7684\u73b0\u91d1\u50a8\u5907\u4e2d\u83b7\u5f97\u5168\u989d\u8d44\u91d1\uff0c\u4ee5\u5b8c\u6210\u5728\u6b27\u76df\uff08European Union\uff09\u3001\u82f1\u56fd\u548c\u6fb3\u5927\u5229\u4e9a\u7684 Presendin \u6ce8\u518c\u8bd5\u9a8c\u3002\u5728\u672c\u5b63\u5ea6\u672b\uff0c\u73b0\u91d1\u548c\u73b0\u91d1\u7b49\u4ef7\u7269\u603b\u8ba1 2930 \u4e07\u6fb3\u5143\u3002 Invex \u8bb0\u5f55\u7684 6 \u6708\u5b63\u5ea6\u73b0\u91d1\u6d41\u51fa\u4e3a 100 \u4e07\u6fb3\u5143\uff0c\u5e76\u8868\u793a\u968f\u7740\u8bd5\u9a8c\u62db\u8058\u7684\u5f00\u59cb\uff0c\u9884\u8ba1\u5728\u968f\u540e\u7684\u671f\u95f4\u8fd9\u5c06\u589e\u52a0\u3002\u5c3d\u7ba1\u8be5\u516c\u53f8\u6b63\u5728\u6fb3\u5927\u5229\u4e9a\u8fdb\u884c\u79ef\u6781\u7684\u7814\u53d1\uff08R&D\uff09\u8bd5\u9a8c\uff0c\u4f46\u9884\u8ba1\u6fb3\u5927\u5229\u4e9a\u653f\u5e9c\u7684\u7814\u53d1\u7a0e\u6536\u4f18\u60e0\u5c06\u5728\u672a\u6765\u8d22\u653f\u5e74\u5ea6\u5f97\u5230\u8ba4\u53ef\u3002 \u4e3a\u5168\u7403 IIH EVOLVE \u4e09\u671f\u8bd5\u9a8c\u505a\u597d\u51c6\u5907 Invex \u5728 6 \u6708\u5b63\u5ea6\u5728\u542f\u52a8\u5176\u5168\u7403 IIH EVOLVE \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u65b9\u9762\u53d6\u5f97\u4e86\u76f8\u5f53\u5927\u7684\u8fdb\u5c55\u3002 6 \u6708\uff0c\u5b83\u83b7\u5f97\u4e86\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u54c1\u76d1\u7ba1\u673a\u6784 (Medicines and Healthcare Products Regulatory Agency; MHRA) \u5bf9\u8be5\u8bd5\u9a8c\u7684\u9996\u6b21\u76d1\u7ba1\u6279\u51c6\u3002 \u5728\u672c\u5b63\u5ea6\u672b\uff0c\u516c\u53f8\u8fd8\u83b7\u5f97\u4e86\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\uff08Human Research Ethics Committee; HREC\uff09\u7684\u6279\u51c6\u548c\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u7528\u54c1\u7ba1\u7406\u5c40\uff08Therapeutics Goods Administration; TGA\uff09\u7684\u4e34\u5e8a\u8bd5\u9a8c\u901a\u77e5\u8ba1\u5212\u6279\u51c6\u3002 \u6b64\u5916\uff0cPeptron \u6839\u636e\u5408\u4f5c\u548c\u5236\u9020\u534f\u8bae\u751f\u4ea7\u7684 Presendin… Continue reading Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d<\/span><\/a><\/p>\n","protected":false},"author":5,"featured_media":18925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[273],"yoast_head":"\nInvex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d<\/title>\n<meta name=\"description\" content=\"Invex Therapeutics (ASX: IXC) \u5df2\u786e\u8ba4\u5176\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\uff0c\u56e0\u4e3a\u5b83\u5c06\u5f00\u59cb\u62db\u52df\u65b0\u8bca\u65ad\u7684\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269 Presendin \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d\" \/>\n<meta property=\"og:description\" content=\"Invex Therapeutics (ASX: IXC) \u5df2\u786e\u8ba4\u5176\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\uff0c\u56e0\u4e3a\u5b83\u5c06\u5f00\u59cb\u62db\u52df\u65b0\u8bca\u65ad\u7684\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269 Presendin \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-06T03:03:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-June-Quarterly-2022.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/\",\"name\":\"Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-07-06T03:03:09+00:00\",\"dateModified\":\"2023-08-29T18:01:33+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"Invex Therapeutics (ASX: IXC) \u5df2\u786e\u8ba4\u5176\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\uff0c\u56e0\u4e3a\u5b83\u5c06\u5f00\u59cb\u62db\u52df\u65b0\u8bca\u65ad\u7684\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269 Presendin \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d","description":"Invex Therapeutics (ASX: IXC) \u5df2\u786e\u8ba4\u5176\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\uff0c\u56e0\u4e3a\u5b83\u5c06\u5f00\u59cb\u62db\u52df\u65b0\u8bca\u65ad\u7684\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269 Presendin \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d","og_description":"Invex Therapeutics (ASX: IXC) \u5df2\u786e\u8ba4\u5176\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\uff0c\u56e0\u4e3a\u5b83\u5c06\u5f00\u59cb\u62db\u52df\u65b0\u8bca\u65ad\u7684\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269 Presendin \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/","og_site_name":"smallcapsCN","article_published_time":"2022-07-06T03:03:09+00:00","article_modified_time":"2023-08-29T18:01:33+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-June-Quarterly-2022.jpg","type":"image\/jpeg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/","url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/","name":"Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-07-06T03:03:09+00:00","dateModified":"2023-08-29T18:01:33+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"Invex Therapeutics (ASX: IXC) \u5df2\u786e\u8ba4\u5176\u5f3a\u5927\u7684\u8d22\u52a1\u72b6\u51b5\uff0c\u56e0\u4e3a\u5b83\u5c06\u5f00\u59cb\u62db\u52df\u65b0\u8bca\u65ad\u7684\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b (IIH) \u60a3\u8005\u7684\u5148\u5bfc\u836f\u7269 Presendin \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-strong-position-launch-presendin-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invex Therapeutics \u5728\u542f\u52a8 Presendin \u8bd5\u9a8c\u65b9\u9762\u5904\u4e8e\u6709\u5229\u5730\u4f4d"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5420"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5420"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5420\/revisions"}],"predecessor-version":[{"id":15299,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5420\/revisions\/15299"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18925"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}